Gene · 3672
Papers3,336
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,336
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ILC1: Development, maturation, and transcriptional regulation. | Eur J Immunol | 2023 | 36408791 | PubTator, text mining | PubMed |
| Endothelial transmigration hotspots limit vascular leakage through heterogeneous expression of ICAM-1. | EMBO Rep | 2023 | 36382783 | PubTator, text mining | PubMed |
| The imminent role of microRNAs in salivary adenoid cystic carcinoma. | Transl Oncol | 2023 | 36335706 | PubTator, text mining | PubMed |
| Single-cell Transcriptomics Reveals Early Molecular and Immune Alterations Underlying the Serrated Neoplasia Pathway Toward Colorectal Cancer. | Cell Mol Gastroenterol Hepatol | 2023 | 36216310 | PubTator, text mining | PubMed |
| Human natural killer cells: Form, function, and development. | J Allergy Clin Immunol | 2023 | 36195172 | PubTator, text mining | PubMed |
| Local immune recognition of trophoblast in early human pregnancy: controversies and questions. | Nat Rev Immunol | 2023 | 36192648 | PubTator, text mining | PubMed |
| Anti-Ro/SSA and/or anti-La/SSB antibodies are associated with adverse endometrial status. | Am J Reprod Immunol | 2023 | 36181668 | PubTator, text mining | PubMed |
| Antiviral Responses of Tissue-resident CD49a+ Lung Natural Killer Cells Are Dysregulated in Chronic Obstructive Pulmonary Disease. | Am J Respir Crit Care Med | 2023 | 36170617 | PubTator, text mining | PubMed |
| FOXP3 expression diversifies the metabolic capacity and enhances the efficacy of CD8 T cells in adoptive immunotherapy of melanoma. | Mol Ther | 2023 | 36045586 | PubTator, text mining | PubMed |
| The role of extravillous trophoblasts and uterine NK cells in vascular remodeling during pregnancy. | Front Immunol | 2022 | 37408837 | PubTator, text mining | PubMed |
| Innate lymphoid cells in depression: Current status and perspectives. | Biomark Neuropsychiatry | 2022 | 37123464 | PubTator, text mining | PubMed |
| Distinct Predictive Immunogenomic Profiles of Response to Immune Checkpoint Inhibitors and IL2: A Real-world Evidence Study of Patients with Advanced Renal Cancer. | Cancer Res Commun | 2022 | 36923304 | PubTator, text mining | PubMed |
| ICAMs are dispensable for influenza clearance and anti-viral humoral and cellular immunity. | Front Immunol | 2022 | 36895258 | PubTator, text mining | PubMed |
| Downregulation of ITGβ3 in colon adenocarcinoma reveals poor prognosis by affecting genome stability, cell cycle, and the tumor immune microenvironment. | Front Oncol | 2022 | 36741730 | PubTator, text mining | PubMed |
| Stromal cells support the survival of human primary chronic lymphocytic leukemia (CLL) cells through Lyn-driven extracellular vesicles. | Front Med (Lausanne) | 2022 | 36714146 | PubTator, text mining | PubMed |
| Uterine NK cells underexpress KIR2DL1/S1 and LILRB1 in reproductive failure. | Front Immunol | 2022 | 36713400 | PubTator, text mining | PubMed |
| Approaches for the isolation and long-term expansion of pericytes from human and animal tissues. | Front Cardiovasc Med | 2022 | 36704463 | PubTator, text mining | PubMed |
| Perioperative corticosteroid treatment impairs tumor-infiltrating dendritic cells in patients with newly diagnosed adult-type diffuse gliomas. | Front Immunol | 2022 | 36703985 | PubTator, text mining | PubMed |
| Defining the altered glycoproteomic space of the early secretory pathway by class I mannosidase pharmacological inhibition. | Front Mol Biosci | 2022 | 36699698 | PubTator, text mining | PubMed |
| Extracellular vesicles derived from different sources play various roles in diabetic retinopathy. | Front Endocrinol (Lausanne) | 2022 | 36686474 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3672/papers?page=28